State Of Wisconsin Investment Board Hille Vax, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.86 - $15.93 $46,574 - $62,557	-3,927 Reduced 14.37%	23,401 $338,000
Q1 2024 May 14, 2024	BUY	$14.15 - $19.75 $198,283 - $276,756	14,013 Added 105.24%	27,328 $454,000
Q4 2023 Feb 12, 2024	SELL	$10.35 - $17.11 $31,029 - $51,295	-2,998 Reduced 18.38%	13,315 $213,000
Q3 2023 Nov 14, 2023	BUY	$11.59 - $16.7 $189,067 - $272,427	16,313 New	16,313 $219,000
Q1 2023 May 15, 2023	SELL	$14.73 - $18.18 $21,019 - $25,942	-1,427 Reduced 12.13%	10,333 $170,000
Q4 2022 Feb 14, 2023	BUY	$13.52 - $21.46 $158,995 - $252,369	11,760 New	11,760 $196,000

36.3M

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $65.2M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.